Enzo Biochem, Inc. (ENZ)
USD 0.31
(-17.77%)
USD 0.31
(-17.77%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 29.65 Million USD | -31.71% |
| 2023 | 43.41 Million USD | 4.89% |
| 2022 | 41.39 Million USD | -8.23% |
| 2021 | 45.1 Million USD | -16.71% |
| 2020 | 54.15 Million USD | 162.75% |
| 2019 | 20.61 Million USD | 0.36% |
| 2018 | 20.53 Million USD | 9.29% |
| 2017 | 18.79 Million USD | -15.6% |
| 2016 | 22.26 Million USD | -13.65% |
| 2015 | 25.78 Million USD | -6.09% |
| 2014 | 27.46 Million USD | 10.61% |
| 2013 | 24.82 Million USD | 23.99% |
| 2012 | 20.02 Million USD | -3.55% |
| 2011 | 20.75 Million USD | 13.88% |
| 2010 | 18.22 Million USD | 11.51% |
| 2009 | 16.34 Million USD | 0.7% |
| 2008 | 16.23 Million USD | -5.11% |
| 2007 | 17.1 Million USD | 188.16% |
| 2006 | 5.93 Million USD | -27.59% |
| 2005 | 8.19 Million USD | 32.92% |
| 2004 | 6.16 Million USD | -5.07% |
| 2003 | 6.49 Million USD | 42.55% |
| 2002 | 4.55 Million USD | -15.81% |
| 2001 | 5.41 Million USD | 5.97% |
| 2000 | 5.1 Million USD | 54.82% |
| 1999 | 3.3 Million USD | -2.94% |
| 1998 | 3.4 Million USD | 0.0% |
| 1997 | 3.4 Million USD | -54.67% |
| 1996 | 7.5 Million USD | -34.21% |
| 1995 | 11.4 Million USD | -17.39% |
| 1994 | 13.8 Million USD | -9.8% |
| 1993 | 15.3 Million USD | -8.93% |
| 1992 | 16.8 Million USD | -65.15% |
| 1991 | 48.2 Million USD | -10.41% |
| 1990 | 53.8 Million USD | -9.58% |
| 1989 | 59.5 Million USD | 17.59% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 28.3 Million USD | -11.65% |
| 2024 Q1 | 32.03 Million USD | -26.22% |
| 2024 Q4 | 29.65 Million USD | 21.34% |
| 2024 Q3 | 24.43 Million USD | -13.65% |
| 2023 Q1 | 40.2 Million USD | -2.87% |
| 2023 Q2 | 43.62 Million USD | 8.49% |
| 2023 Q4 | 43.41 Million USD | -18.28% |
| 2023 FY | 43.41 Million USD | 4.89% |
| 2023 Q3 | 53.13 Million USD | 21.8% |
| 2022 Q2 | 43.69 Million USD | 5.6% |
| 2022 Q4 | 41.39 Million USD | -0.77% |
| 2022 FY | 41.39 Million USD | -8.23% |
| 2022 Q1 | 41.37 Million USD | -8.26% |
| 2022 Q3 | 41.71 Million USD | -4.53% |
| 2021 Q1 | 54.48 Million USD | 0.61% |
| 2021 Q4 | 45.1 Million USD | -7.3% |
| 2021 Q2 | 50.24 Million USD | -7.79% |
| 2021 Q3 | 48.65 Million USD | -3.16% |
| 2021 FY | 45.1 Million USD | -16.71% |
| 2020 Q2 | 45.92 Million USD | -2.1% |
| 2020 Q3 | 54.01 Million USD | 17.63% |
| 2020 Q1 | 46.9 Million USD | 127.58% |
| 2020 Q4 | 54.15 Million USD | 0.26% |
| 2020 FY | 54.15 Million USD | 162.75% |
| 2019 Q4 | 20.61 Million USD | 3.05% |
| 2019 Q1 | 18.51 Million USD | -9.86% |
| 2019 FY | 20.61 Million USD | 0.36% |
| 2019 Q3 | 20 Million USD | -7.5% |
| 2019 Q2 | 21.62 Million USD | 16.8% |
| 2018 Q3 | 19.07 Million USD | -6.35% |
| 2018 FY | 20.53 Million USD | 9.29% |
| 2018 Q1 | 20.07 Million USD | 6.82% |
| 2018 Q2 | 20.36 Million USD | 1.45% |
| 2018 Q4 | 20.53 Million USD | 7.69% |
| 2017 Q1 | 21.98 Million USD | -1.29% |
| 2017 Q2 | 18.66 Million USD | -15.09% |
| 2017 Q3 | 18.01 Million USD | -3.47% |
| 2017 FY | 18.79 Million USD | -15.6% |
| 2017 Q4 | 18.79 Million USD | 4.32% |
| 2016 Q4 | 22.26 Million USD | -5.33% |
| 2016 Q3 | 23.52 Million USD | -11.11% |
| 2016 Q2 | 26.45 Million USD | -2.66% |
| 2016 FY | 22.26 Million USD | -13.65% |
| 2016 Q1 | 27.18 Million USD | 5.41% |
| 2015 Q1 | 26.5 Million USD | -3.48% |
| 2015 Q4 | 25.78 Million USD | 5.45% |
| 2015 Q2 | 24.68 Million USD | -6.89% |
| 2015 FY | 25.78 Million USD | -6.09% |
| 2015 Q3 | 24.45 Million USD | -0.91% |
| 2014 Q1 | 25.19 Million USD | 1.47% |
| 2014 FY | 27.46 Million USD | 10.61% |
| 2014 Q2 | 23.54 Million USD | -6.54% |
| 2014 Q3 | 24.59 Million USD | 4.46% |
| 2014 Q4 | 27.46 Million USD | 11.66% |
| 2013 Q3 | 22.2 Million USD | 1.23% |
| 2013 Q4 | 24.82 Million USD | 11.8% |
| 2013 FY | 24.82 Million USD | 23.99% |
| 2013 Q1 | 21.29 Million USD | 6.35% |
| 2013 Q2 | 21.93 Million USD | 3.02% |
| 2012 FY | 20.02 Million USD | -3.55% |
| 2012 Q2 | 19.91 Million USD | -2.76% |
| 2012 Q4 | 20.02 Million USD | 4.75% |
| 2012 Q3 | 19.11 Million USD | -4.03% |
| 2012 Q1 | 20.48 Million USD | -1.33% |
| 2011 Q4 | 20.75 Million USD | 11.44% |
| 2011 Q1 | 18.52 Million USD | 1.62% |
| 2011 Q2 | 19.6 Million USD | 5.83% |
| 2011 Q3 | 18.62 Million USD | -4.98% |
| 2011 FY | 20.75 Million USD | 13.88% |
| 2010 Q2 | 21.61 Million USD | 38.76% |
| 2010 FY | 18.22 Million USD | 11.51% |
| 2010 Q4 | 18.22 Million USD | 26.17% |
| 2010 Q1 | 15.58 Million USD | -4.69% |
| 2010 Q3 | 14.44 Million USD | -33.17% |
| 2009 Q1 | 15.38 Million USD | -5.25% |
| 2009 FY | 16.34 Million USD | 0.7% |
| 2009 Q2 | 16.55 Million USD | 7.63% |
| 2009 Q3 | 17.99 Million USD | 8.67% |
| 2009 Q4 | 16.34 Million USD | -9.13% |
| 2008 FY | 16.23 Million USD | -5.11% |
| 2008 Q1 | 15.94 Million USD | -6.81% |
| 2008 Q2 | 13.22 Million USD | -17.04% |
| 2008 Q3 | 13.82 Million USD | 4.49% |
| 2008 Q4 | 16.23 Million USD | 17.45% |
| 2007 Q4 | 17.1 Million USD | 72.77% |
| 2007 FY | 17.1 Million USD | 188.16% |
| 2007 Q1 | 7.91 Million USD | 33.33% |
| 2007 Q2 | 7.86 Million USD | -0.67% |
| 2007 Q3 | 9.9 Million USD | 25.93% |
| 2006 Q1 | 6.17 Million USD | -24.66% |
| 2006 FY | 5.93 Million USD | -27.59% |
| 2006 Q4 | 5.93 Million USD | -14.86% |
| 2006 Q3 | 6.97 Million USD | 31.0% |
| 2006 Q2 | 5.32 Million USD | -13.83% |
| 2005 Q4 | 8.19 Million USD | 36.13% |
| 2005 Q1 | 11.66 Million USD | 89.04% |
| 2005 FY | 8.19 Million USD | 32.92% |
| 2005 Q3 | 6.02 Million USD | -14.65% |
| 2005 Q2 | 7.05 Million USD | -39.48% |
| 2004 FY | 6.16 Million USD | -5.07% |
| 2004 Q4 | 6.16 Million USD | 18.21% |
| 2004 Q1 | 6.25 Million USD | -3.8% |
| 2004 Q3 | 5.21 Million USD | 0.15% |
| 2004 Q2 | 5.21 Million USD | -16.65% |
| 2003 FY | 6.49 Million USD | 42.55% |
| 2003 Q1 | 4.98 Million USD | 9.25% |
| 2003 Q3 | 5.53 Million USD | 1.73% |
| 2003 Q2 | 5.44 Million USD | 9.32% |
| 2003 Q4 | 6.49 Million USD | 17.33% |
| 2002 Q2 | 6.14 Million USD | 24.74% |
| 2002 Q1 | 4.92 Million USD | -8.98% |
| 2002 FY | 4.55 Million USD | -15.81% |
| 2002 Q4 | 4.55 Million USD | -28.55% |
| 2002 Q3 | 6.38 Million USD | 3.79% |
| 2001 Q4 | 5.41 Million USD | 31.47% |
| 2001 Q3 | 4.11 Million USD | -3.96% |
| 2001 Q2 | 4.28 Million USD | -1.85% |
| 2001 FY | 5.41 Million USD | 5.97% |
| 2001 Q1 | 4.36 Million USD | -14.48% |
| 2000 Q1 | 3.5 Million USD | 6.06% |
| 2000 Q4 | 5.1 Million USD | 74.96% |
| 2000 Q3 | 2.92 Million USD | -5.81% |
| 2000 Q2 | 3.1 Million USD | -11.43% |
| 2000 FY | 5.1 Million USD | 54.82% |
| 1999 FY | 3.3 Million USD | -2.94% |
| 1999 Q3 | 2.7 Million USD | -10.0% |
| 1999 Q2 | 3 Million USD | -6.25% |
| 1999 Q1 | 3.2 Million USD | -5.88% |
| 1999 Q4 | 3.3 Million USD | 22.22% |
| 1998 Q3 | 3 Million USD | -9.09% |
| 1998 Q2 | 3.3 Million USD | 26.92% |
| 1998 FY | 3.4 Million USD | 0.0% |
| 1998 Q4 | 3.4 Million USD | 13.33% |
| 1998 Q1 | 2.6 Million USD | -23.53% |
| 1997 Q3 | 2.9 Million USD | 16.0% |
| 1997 Q1 | 3.8 Million USD | -49.33% |
| 1997 FY | 3.4 Million USD | -54.67% |
| 1997 Q4 | 3.4 Million USD | 17.24% |
| 1997 Q2 | 2.5 Million USD | -34.21% |
| 1996 FY | 7.5 Million USD | -34.21% |
| 1996 Q1 | 10.2 Million USD | -10.53% |
| 1996 Q3 | 10.5 Million USD | -0.94% |
| 1996 Q4 | 7.5 Million USD | -28.57% |
| 1996 Q2 | 10.6 Million USD | 3.92% |
| 1995 Q3 | 12 Million USD | -0.83% |
| 1995 Q1 | 15.1 Million USD | 9.42% |
| 1995 Q2 | 12.1 Million USD | -19.87% |
| 1995 FY | 11.4 Million USD | -17.39% |
| 1995 Q4 | 11.4 Million USD | -5.0% |
| 1994 Q2 | 8.2 Million USD | -42.25% |
| 1994 Q1 | 14.2 Million USD | -7.19% |
| 1994 FY | 13.8 Million USD | -9.8% |
| 1994 Q4 | 13.8 Million USD | 32.69% |
| 1994 Q3 | 10.4 Million USD | 26.83% |
| 1993 Q2 | 16.4 Million USD | -1.2% |
| 1993 Q1 | 16.6 Million USD | -1.19% |
| 1993 FY | 15.3 Million USD | -8.93% |
| 1993 Q4 | 15.3 Million USD | -6.13% |
| 1993 Q3 | 16.3 Million USD | -0.61% |
| 1992 Q4 | 16.8 Million USD | 17.48% |
| 1992 Q3 | 14.3 Million USD | 3.62% |
| 1992 Q1 | 48.3 Million USD | 0.21% |
| 1992 FY | 16.8 Million USD | -65.15% |
| 1992 Q2 | 13.8 Million USD | -71.43% |
| 1991 Q1 | 53.2 Million USD | -1.12% |
| 1991 Q3 | 56.8 Million USD | 0.35% |
| 1991 Q4 | 48.2 Million USD | -15.14% |
| 1991 Q2 | 56.6 Million USD | 6.39% |
| 1991 FY | 48.2 Million USD | -10.41% |
| 1990 Q4 | 53.8 Million USD | -6.27% |
| 1990 FY | 53.8 Million USD | -9.58% |
| 1990 Q2 | 58.7 Million USD | 0.69% |
| 1990 Q3 | 57.4 Million USD | -2.21% |
| 1990 Q1 | 58.3 Million USD | -2.02% |
| 1989 FY | 59.5 Million USD | 17.59% |
| 1989 Q4 | 59.5 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Agilent Technologies, Inc. | 4.91 Billion USD | 99.397% |
| Charles River Laboratories International, Inc. | 4.53 Billion USD | 99.346% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | 99.61% |
| Danaher Corporation | 30.99 Billion USD | 99.904% |
| IQVIA Holdings Inc. | 20.56 Billion USD | 99.856% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | 99.664% |
| Mettler-Toledo International Inc. | 3.5 Billion USD | 99.154% |
| Qiagen N.V. | 2.3 Billion USD | 98.715% |
| Revvity, Inc. | 5.69 Billion USD | 99.479% |
| Thermo Fisher Scientific Inc. | 51.88 Billion USD | 99.943% |
| Waters Corporation | 3.47 Billion USD | 99.147% |